Literature DB >> 18830228

Misleading behavioural phenotype with adenylosuccinate lyase deficiency.

Cyril Gitiaux1, Irène Ceballos-Picot, Sandrine Marie, Vassili Valayannopoulos, Marlène Rio, Séverine Verrieres, Jean François Benoist, Marie Françoise Vincent, Isabelle Desguerre, Nadia Bahi-Buisson.   

Abstract

Adenylosuccinate lyase deficiency is a rare autosomal disorder of de novo purine synthesis, which results in the accumulation of succinylpurines in body fluids. Patients with adenylosuccinate lyase deficiency show a variable combination of mental retardation, epilepsy and autistic features and are usually discovered during screens for unexplained encephalopathy using the Bratton-Marshall assay that reveals the excretion of the succinylaminoimidazolecarboxamide riboside (SAICAr). Here, we report on two sisters aged 11 and 12 years presented with global developmental delay, motor apraxia, severe speech deficits, seizures and behavioural features, which combined excessive laughter, a very happy disposition, hyperactivity, a short attention span, the mouthing of objects, tantrums and stereotyped movements that gave a behavioural profile mimicking Angelman syndrome. Both patients had an increased succinyladenosine/SAICAr ratio of 1.6, and exhibited a novel homozygous missense mutation (c.674T>C; p.Met225Thr) in the exon 6 of the ADSL gene. We suggest that these clinical features might be a new presentation of adenylosuccinate lyase deficiency. On the basis of this observation, although adenylosuccinate lyase deficiency is a rare disorder, this diagnosis should be considered in patients with mental retardation and a behavioural profile suggestive of Angelman syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830228      PMCID: PMC2985950          DOI: 10.1038/ejhg.2008.174

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  19 in total

1.  Adenylosuccinase deficiency: an unusual cause of early-onset epilepsy associated with acquired microcephaly.

Authors:  M Nassogne; B Henrot; G Aubert; C Bonnier; S Marie; C Saint-Martin; G Van den Berghe; G Sébire; M Vincent
Journal:  Brain Dev       Date:  2000-09       Impact factor: 1.961

2.  Adenylosuccinate lyase deficiency: from the clinics to molecular biology.

Authors:  S Marie; V Race; M F Vincent; G Van den Berghe
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

Review 3.  Angelman syndrome: mimicking conditions and phenotypes.

Authors:  C A Williams; A Lossie; D Driscoll
Journal:  Am J Med Genet       Date:  2001-06-01

4.  Towards a suggestive facial dysmorphism in adenylosuccinate lyase deficiency?

Authors:  M Holder-Espinasse; S Marie; G Bourrouillou; I Ceballos-Picot; M-C Nassogne; L Faivre; J Amiel; A Munnich; M-F Vincent; V Cormier-Daire
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

Review 5.  A behavioral neurogenetics approach to developmental disabilities: gene-brain-behavior associations.

Authors:  T L Baumgardner; K E Green; A L Reiss
Journal:  Curr Opin Neurol       Date:  1994-04       Impact factor: 5.710

6.  Clinical, biochemical and molecular genetic correlations in adenylosuccinate lyase deficiency.

Authors:  V Race; S Marie; M F Vincent; G Van den Berghe
Journal:  Hum Mol Genet       Date:  2000-09-01       Impact factor: 6.150

7.  Detection of 5'-phosphoribosyl-4-(N-succinylcarboxamide)-5-aminoimidazole in urine by use of the Bratton-Marshall reaction: identification of patients deficient in adenylosuccinate lyase activity.

Authors:  P K Laikind; J E Seegmiller; H E Gruber
Journal:  Anal Biochem       Date:  1986-07       Impact factor: 3.365

8.  An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids.

Authors:  J Jaeken; G Van den Berghe
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

9.  Residual adenylosuccinase activities in fibroblasts of adenylosuccinase-deficient children: parallel deficiency with adenylosuccinate and succinyl-AICAR in profoundly retarded patients and non-parallel deficiency in a mildly retarded girl.

Authors:  F Van den Bergh; M F Vincent; J Jaeken; G Van den Berghe
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

10.  Adenylosuccinase deficiency: an inborn error of purine nucleotide synthesis.

Authors:  J Jaeken; S K Wadman; M Duran; F J van Sprang; F A Beemer; R A Holl; P M Theunissen; P de Cock; F van den Bergh; M F Vincent
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

View more
  16 in total

1.  Testing for Ancient Selection Using Cross-population Allele Frequency Differentiation.

Authors:  Fernando Racimo
Journal:  Genetics       Date:  2015-11-23       Impact factor: 4.562

2.  Structural and biochemical characterization of human adenylosuccinate lyase (ADSL) and the R303C ADSL deficiency-associated mutation.

Authors:  Stephen P Ray; Michelle K Deaton; Glenn C Capodagli; Lauren A F Calkins; Lucas Sawle; Kingshuk Ghosh; David Patterson; Scott D Pegan
Journal:  Biochemistry       Date:  2012-08-07       Impact factor: 3.162

3.  Metabolic disorders of purine metabolism affecting the nervous system.

Authors:  H A Jinnah; Richard L Sabina; Georges Van Den Berghe
Journal:  Handb Clin Neurol       Date:  2013

4.  Novel proton MR spectroscopy findings in adenylosuccinate lyase deficiency.

Authors:  Maria Zulfiqar; Doris D M Lin; Marinette Van der Graaf; Peter B Barker; Jill A Fahrner; Sandrine Marie; Eva Morava; Lonneke De Boer; Michel A A P Willemsen; Eileen Vining; Alena Horská; Udo Engelke; Ron A Wevers; Gustavo H B Maegawa
Journal:  J Magn Reson Imaging       Date:  2012-10-10       Impact factor: 4.813

Review 5.  Magnetic resonance imaging of the brain in adenylosuccinate lyase deficiency: a report of seven cases and a review of the literature.

Authors:  Agnieszka Jurecka; Elzbieta Jurkiewicz; Anna Tylki-Szymanska
Journal:  Eur J Pediatr       Date:  2011-05-31       Impact factor: 3.183

6.  Molecular characterization of the AdeI mutant of Chinese hamster ovary cells: a cellular model of adenylosuccinate lyase deficiency.

Authors:  Lydia K Vliet; Terry G Wilkinson; Nathan Duval; Guido Vacano; Christine Graham; Marie Zikánová; Vaclava Skopova; Veronika Baresova; Aleš Hnízda; Stanislav Kmoch; David Patterson
Journal:  Mol Genet Metab       Date:  2010-09-06       Impact factor: 4.797

Review 7.  Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements.

Authors:  Irena Vrečar; Josie Innes; Elizabeth A Jones; Helen Kingston; William Reardon; Bronwyn Kerr; Jill Clayton-Smith; Sofia Douzgou
Journal:  J Pediatr Genet       Date:  2017-04-12

Review 8.  The molecular basis of cognitive deficits in pervasive developmental disorders.

Authors:  Aditi Bhattacharya; Eric Klann
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

9.  Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes.

Authors:  Simon C Ramsden; Jill Clayton-Smith; Rachael Birch; Karin Buiting
Journal:  BMC Med Genet       Date:  2010-05-11       Impact factor: 2.103

Review 10.  Mental retardation and inborn errors of metabolism.

Authors:  A García-Cazorla; N I Wolf; M Serrano; U Moog; B Pérez-Dueñas; P Póo; M Pineda; J Campistol; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2009-08-14       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.